NON-CORRELATION BETWEEN DEBRISOQUINE AND METOPROLOL POLYMORPHISMS IN THE VENDA

被引：25

作者：

SOMMERS, DK

MONCRIEFF, J

AVENANT, J

机构：

来源：

HUMAN TOXICOLOGY | 1989年 / 8卷 / 05期

关键词：

D O I：

10.1177/096032718900800506

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

引用

页码：365 / 368

页数：4

共 20 条

[1] GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS [J].

CLARK, DWJ .

DRUGS, 1985, 29 (04) :342-375

[2] INTERINDIVIDUAL VARIATION OF BETA-ADRENOCEPTOR BLOCKING-DRUGS, PLASMA-CONCENTRATION AND EFFECT - INFLUENCE OF GENETIC STATUS ON BEHAVIOR OF ATENOLOL, BOPINDOLOL AND METOPROLOL [J].

DAYER, P ;

LEEMANN, T ;

MARMY, A ;

ROSENTHALER, J .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (02) :149-153

[3]

EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001

[4] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].

EVANS, DAP ;

MAHGOUB, A ;

SLOAN, TP ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105

[5] THE POLYMORPHIC 4-HYDROXYLATION OF DEBRISOQUINE IN A SAUDI-ARAB POPULATION [J].

ISLAM, SI ;

IDLE, JR ;

SMITH, RL .

XENOBIOTICA, 1980, 10 (11) :819-825

[6] METOPROLOL AND DEBRISOQUIN METABOLISM IN NIGERIANS - LACK OF EVIDENCE FOR POLYMORPHIC OXIDATION [J].

IYUN, AO ;

LENNARD, MS ;

TUCKER, GT ;

WOODS, HF .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (04) :387-394

[7] THE UPJOHN-AWARD-LECTURE 1981 - THE METABOLISM OF XENOBIOTICS IN DIFFERENT POPULATIONS [J].

KALOW, W .

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1982, 60 (01) :1-12

[8] THE POLYMORPHIC OXIDATION OF BETA-ADRENOCEPTOR ANTAGONISTS - CLINICAL PHARMACOKINETIC CONSIDERATIONS [J].

LENNARD, MS ;

TUCKER, GT ;

WOODS, HF .

CLINICAL PHARMACOKINETICS, 1986, 11 (01) :1-17

[9] OXIDATION PHENOTYPE - A MAJOR DETERMINANT OF METOPROLOL METABOLISM AND RESPONSE [J].

LENNARD, MS ;

SILAS, JH ;

FREESTONE, S ;

RAMSAY, LE ;

TUCKER, GT ;

WOODS, HF .

NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (25) :1558-1560

[10]

LENNARD MS, 1983, PHARM INT, V4, P61

← 1 2 →